Results 21 - 39 of 39 in Levaquin, Levofloxacin (generic)
-
FDA Approves New Indication For Wyeth's TYGACIL (tigecycline)...
March 26, 2009 Wyeth Pharmaceuticals, a division of Wyeth , announced recently that the U.S. Food and Drug Administration approved TYGACIL , for the treatment of adult patients with community-acquired bacterial pneumonia caused by susceptible strains of indicated pathogens. Comment?
-
Novexel Strengthens its Scientific Advisory Board With the Appointment of Dr. Karen Bush
Karen Bush to the Company's Scientific Advisory Board . Novexel's SAB is chaired by Dr. Comment?
-
Company and People Notes: Daiichi Sankyo Sues 13 Generic Drugmakers; Ischemix Appoints CEO; More...
Daiichi Sankyo is suing 13 generic-drug companies for the substance patent and usage patent for Cravit tablets and fine granules , according to a company press release. Comment?
-
Drug-resistance in Streptococcus pneumoniae isolates among Spanish...
Pneumococcal diseases remain a major cause of morbidity and mortality worldwide. Comment?
-
FDA Approves New Indication For Wyeth's TYGACIL (tigecycline) For The ...
Main Category: Infectious Diseases / Bacteria / Viruses Also Included In: Respiratory / Asthma ; Regulatory Affairs / Drug Approvals ; Clinical Trials / Drug Trials Article Date: 25 Mar 2009 - 1:00 PDT Wyeth Pharmaceuticals, a division of Wyeth , announced that the U.S. Food and Drug Administration approved TYGACIL , for the treatment of adult ... Comment?
-
FDA approves new indication for Wyeth's Tygacil
Wyeth Pharmaceuticals, a division of Wyeth has announced that the U.S. Food and Drug Administration approved Tygacil , for the treatment of adult patients with community-acquired bacterial pneumonia caused by susceptible strains of indicated pathogens. Comment?
-
Daiichi Sankyo Files Patent Infringement Actions Against 13 Generics...
TOKYO, March 23, 2009 Daiichi Sankyo Company, Limited announced that it has brought patent infringement litigation against 13 generics companies for the substance patent and usage patent for Levofloxacin Hydrate* . Levofloxacin Hydrate broad-spectrum oral anti-bacterial agents originated by Daiichi Sankyo, has been marketed by the company in Japan ... Comment?
-
Cumulative H. pylori eradication rates in clinical practice
A recent study in the American College of Gastroenterology examines the cumulative H. pylori eradication rates in clinical practice by adopting regimens proposed by the Maastricht III consensus. Comment?
-
Drug News: Fluoroquinolone-induced tendinopathy
DRUG NEWS: Fluoroquinolone-induced tendinopathy On July 8, 2008, the FDA requested that the different manufacturers of fluoroquinolone antibiotics strengthen the warnings section in their prescribing ... Comment?
-
Pharmacodynamic modeling of aminoglycosides against Pseudomonas...
Abstract To facilitate optimal dosing regimen design, we previously developed a mathematical model using time-kill study data to predict the responses of Pseudomonas aeruginosa to various pharmacokinetic ... Comment?
-
San Diego--- Mpex Pharmaceuticals Announces Series D Financing of Up to $40 Million
Mpex Pharmaceuticals, Inc. today announced that it has completed a $27.5 million initial closing of a Series D financing led by Investor Growth Capital. Comment?
-
Mpex Pharmaceuticals, Inc. Announces Series D Financing of Up to $40 Million
Mpex Pharmaceuticals, Inc. today announced that it has completed a $27.5 million initial closing of a Series D financing led by Investor Growth Capital. Comment?
-
Pharmaceuticals Sold In Sweden Cause Serious Environmental Harm In India, Research Shows
Some of these factories release large quantities of antibiotics and other pharmaceutical substances into the environment. Comment?
-
Pharmaceuticals Sold In Sweden Cause Serious Environmental Harm In India
Infectious Diseases / Bacteria / Viruses Water - Air Quality / Agriculture Article Date: 06 Feb 2009 Many of the substances in our most common medicines are manufactured in India and China. Comment?
-
The Mulligan Law Firm Is Now Evaluating Potential Cipro, Levaquin,...
Fluoroquinolones are drugs that actively kill bacteria. Cipro falls into this specific category. 1 comment
-
Rib-X Pharmaceuticals, Inc. Raises $25 Million
Rib-X Pharmaceuticals, Inc. , a development-stage company focused on the discovery and development of novel antibiotics for the treatment of antibiotic-resistant infections, today announced positive final ... Comment?
-
Rib-X Pharmaceuticals Announces Positive Phase 2 Study Results for...
Rib-X Pharmaceuticals, Inc. , a development-stage company focused on the discovery and development of novel antibiotics for the treatment of antibiotic-resistant infections, today announced positive final ... Comment?
-
TaiGen Biotechnology Secures $37 Million USD in Series C Round Financing
TaiGen Biotechnology Co., Ltd., a privately-held pharmaceutical company focused on developing drugs to treat infectious diseases, cancer and diabetes-related complications, announced that it has raised 37 ... Comment?
-
TaiGen Biotechnology Secures 37 Million USD in Series C Round Financing
20 /PRNewswire-Asia/ -- TaiGen Biotechnology Co., Ltd., a privately-held pharmaceutical company focused on developing drugs to treat infectious diseases, cancer and diabetes-related complications, announced ... Comment?
- « Previous
- 1
- 2
- Next »





